Categories: Technology

Melexis: update on the share buy-back program

 | Source: Melexis N.V.

Press release – Regulated Information

Ieper, Belgium – 30 December 2024, 17.45 hrs CET

Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 17,600 Melexis shares in the period from 23 December 2024 until 27 December 2024.

Trade date Total shares purchased Average price (€) Min price (€) Max price (€) Buyback amount (€)
23/12/2024 7,000 55.31 54.60 55.50 387,185
24/12/2024 4,100 55.78 55.65 56.10 228,714
27/12/2024 6,500 56.44 55.90 56.60 366,838
TOTAL 17,600 55.84 54.60 56.60 982,738
GlobeNews Wire

Recent Posts

Renowned Biomedical Scientist Franco Cavaleri Challenges Conventional Alzheimer’s Theories in Groundbreaking Study

VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Franco Cavaleri, B.Sc., Ph.D.c, a distinguished…

3 hours ago

Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order

March 31, 2025 20:10 ET  | Source: Avicanna Inc. Auditor Licensing & Personnel Issues Delays…

3 hours ago

Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market

BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES…

3 hours ago

Total number of shares and voting rights in Zealand Pharma as of March 31, 2025

March 31, 2025 17:00 ET  | Source: Zealand Pharma Company announcement – No. 8 /…

3 hours ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Transformational 2024: successfully advanced from preclinical to clinical stage company Strengthened leadership team to drive…

3 hours ago

Firstever joint Chefs de Mission Seminar provides key insights into Milano Cortina 2026 preparations

31 March 2025 - Delegations from around the world gathered in Milan from 24 to 30…

4 hours ago